Glendale Prescription Center Philadelphia, PA - 19152

Glendale Prescription Center is categorized under in Philadelphia, PA and active since 2001.

Glendale Prescription Center was established in 2001, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a business, which does work in the B2C market, and is classified as a , under code number 4461100 by the NAICS.

If you are seeking more information, feel free to contact Steven Tammara, Owner at the company’s single location by writing to 7601 Castor Avenue # 100, Philadelphia, Pennsylvania PA 19152 or by phoning (215) 722-6200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Glendale Prescription Center
Contact Person: Steven Tammara, Owner
Address: 7601 Castor Avenue # 100, Philadelphia, Pennsylvania 19152
Phone Number: (215) 722-6200
Website Address: glendalerx.com
Annual Revenue (USD): $5.000.000 to $9.999.999
Founded: 2001
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category:
SIC Code: 5912
NAICS Code: 4461100
Share This Business:

Glendale Prescription Center was started in 2001 to provide professional under the SIC code 5912 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.

Feel free to contact Steven Tammara, Owner for inquiries that concern Glendale Prescription Center by calling the company number (215) 722-6200, as your correspondence is most welcome. Additionally, the physical location of the single location of Glendale Prescription Center can be found at the coordinates 40.055568,-75.061962 as well as the street address 7601 Castor Avenue # 100 in Philadelphia, Pennsylvania 19152.

For its online presence, you may visit Glendale Prescription Center’s website at glendalerx.com and engage with its social media outlets through on Twitter and on Facebook.